文献速递肝病

内皮POFUT1通过抑制纤维蛋白原合成控制损伤诱导的肝纤维化

Endothelial POFUT1 controls injury-induced liver fibrosis by repressing fibrinogen synthesis.
PubMed 文献 · J Hepatol · 2024-03-07

该研究利用内皮特异性Pofut1敲除小鼠,通过慢性四氯化碳暴露或胆总管结扎诱导肝纤维化,发现POFUT1缺失促进肝窦内皮细胞毛细血管化和肝星状细胞活化,加重肝纤维化;机制上POFUT1缺失通过增强NOTCH/HES1/STAT3信号上调内皮细胞纤维蛋白原表达,后者作为促纤维化旁分泌信号激活肝星状细胞。

要点

  • 内皮特异性Pofut1敲除加重小鼠实验性肝纤维化。
  • POFUT1缺失通过NOTCH/HES1/STAT3通路上调肝窦内皮细胞纤维蛋白原表达。
  • 内皮来源纤维蛋白原作为旁分泌信号激活肝星状细胞,促进纤维化。

核心结论

  • 内皮POFUT1通过抑制纤维蛋白原表达预防损伤诱导的肝纤维化,纤维蛋白原作为促纤维化旁分泌信号激活肝星状细胞。
  • 靶向POFUT1/纤维蛋白原轴可能为纤维化肝病的防治提供策略。

研究设计与样本

  • 研究采用内皮特异性Pofut1敲除小鼠,通过慢性四氯化碳暴露或胆总管结扎诱导实验性肝纤维化。
  • 肝脏样本采用ELISA、组织学、电子显微镜、免疫染色和RNA原位杂交评估。
  • 分离肝窦内皮细胞和肝星状细胞进行RNA测序、qPCR和蛋白质印迹基因表达分析。
  • 通过用肝窦内皮细胞培养上清处理肝星状细胞研究信号串扰。
  • 分析肝硬化和健康个体的肝脏单细胞RNA测序数据集以评估临床相关性。

主要发现

  • POFUT1缺失促进损伤诱导的肝窦内皮细胞毛细血管化和肝星状细胞活化,导致肝纤维化加重。
  • RNA测序显示POFUT1缺陷上调肝窦内皮细胞中纤维蛋白原表达,肝硬化患者肝窦内皮细胞中纤维蛋白原也升高。
  • Pofut1缺失小鼠肝窦内皮细胞上清处理的肝星状细胞较对照上清处理活化加剧,该效应可被纤维蛋白原敲低或纤维蛋白原受体信号药理学抑制减弱。
  • 机制上POFUT1缺失通过增强NOTCH/HES1/STAT3信号增加纤维蛋白原表达。

临床怎么用

  • 作者认为靶向POFUT1/纤维蛋白原轴是预防和治疗纤维化肝病的有前景策略。
  • 作者指出纤维蛋白原与肝硬化相关,可能作为该人类疾病的潜在治疗靶点。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: NOTCH signaling in liver sinusoidal endothelial cells (LSECs) regulates liver fibrosis, a pathological feature of chronic liver diseases. POFUT1 is an essential regulator of NOTCH signaling. Here, we investigated the role of LSEC-expressed POFUT1 in liver fibrosis. METHODS: Endothelial-specific Pofut1 knockout mice were generated and experimental liver fibrosis was induced by chronic carbon tetrachloride exposure or common bile duct ligation. Liver samples were assessed by ELISA, histology, electron microscopy, immunostaining and RNA in situ hybridization. LSECs and hepatic stellate cells (HSCs) were isolated for gene expression analysis by RNA sequencing, qPCR, and western blotting. Signaling crosstalk between LSECs and HSCs was investigated by treating HSCs with supernatant from LSEC cultures. Liver single-cell RNA sequencing datasets from patients with cirrhosis and healthy individuals were analyzed to evaluate the clinical relevance of gene expression changes observed in mouse studies. RESULTS: POFUT1 loss promoted injury-induced LSEC capillarization and HSC activation, leading to aggravated liver fibrosis. RNA sequencing analysis revealed that POFUT1 deficiency upregulated fibrinogen expression in LSECs. Consistently, fibrinogen was elevated in LSECs of patients with cirrhosis. HSCs treated with supernatant from LSECs of Pofut1 null mice showed exacerbated activation compared to those treated with supernatant from control LSECs, and this effect was attenuated by knockdown of fibrinogen or by pharmacological inhibition of fibrinogen receptor signaling, altogether suggesting that LSEC-derived fibrinogen induced the activation of HSCs. Mechanistically, POFUT1 loss augmented fibrinogen expression by enhancing NOTCH/HES1/STAT3 signaling. CONCLUSIONS: Endothelial POFUT1 prevents injury-induced liver fibrosis by repressing the expression of fibrinogen, which functions as a profibrotic paracrine signal to activate HSCs. Therapies targeting the POFUT1/fibrinogen axis offer a promising strategy for the prevention and treatment of fibrotic liver diseases. IMPACT AND IMPLICATIONS: Paracrine signals produced by liver vasculature play a major role in the development of liver fibrosis, which is a pathological hallmark of most liver diseases. Identifying those paracrine signals is clinically relevant in that they may serve as therapeutic targets. In this study, we discovered that genetic deletion of Pofut1 aggravated experimental liver fibrosis in mouse models. Moreover, fibrinogen was identified as a downstream target repressed by Pofut1 in liver endothelial cells and functioned as a novel paracrine signal that drove liver fibrosis. In addition, fibrinogen was found to be relevant to cirrhosis and may serve as a potential therapeutic target for this devastating human disease.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. He S, Luo Y, Ma W, et al. Endothelial POFUT1 controls injury-induced liver fibrosis by repressing fibrinogen synthesis. J Hepatol. 2024. PMID: 38460791. doi:10.1016/j.jhep.2024.02.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。